证券代码：600030 证券简称：中信证券 公告编号：临2025-048 中信证券股份有限公司 关于间接子公司发行中期票据 并由全资子公司提供担保的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 一、担保情况概述 公司境外全资子公司中信证券国际的附属公司CSI MTN Limited（以下简称发 行人或被担保人）于2022年3月29日设立本金总额最高为50亿美元（或等值其他货 币）的境外中期票据计划（以下简称中票计划），此中票计划由中信证券国际提 供担保。 发行人于2025年6月25日在中票计划下发行三笔票据，发行金额合计2,050万 美元。 本次发行后，发行人在中票计划下已发行票据的本金余额合计34.29亿美元。 二、被担保人基本情况 3. 注册日期：2021年12月30日 4. 实收资本：1美元 5. 最新信用等级状况：不适用 6. 经营情况：被担保人系特殊目的公司（SPV），自成立以来未开展除作为 债券发行人外的其他业务活动，也未进行任何投资，本次担保发生前处于正常存 续状态，无任何正在进行的投资。 ...

25日，两市主要股指早盘窄幅震荡，午后在金融、地产等板块的带动下强势拉升，截至收盘，沪指涨 1.03%报3455.97点，深证成指涨1.72%报10393.72点，创业板指涨3.11%报2128.39点，沪深北三市合计成 交16402亿元，较此前一日增加超1900亿元。行业方面，券商、军工板块大幅走高，半导体、地产、汽 车等板块均上扬，互联金融、数字货币、大飞机、AI应用概念等活跃。石油、农药等板块疲弱。 东莞证券表示，中东紧张局势降温，提振了A股市场风险偏好，当前市场已逐步回归自身演绎节奏之 中，叠加大金融板块持续发力带动指数继续上扬，预计短期市场仍有望走高，个股活跃度也将进一步加 强。板块上建议关注金融、机械设备、大消费和TMT等板块。 今日投资机会解析 稳定币叠加政策催化推升券商板块行情 国泰君安国际25日大涨198%，主要原因是香港证监会批准其升级虚拟资产交易牌照，成为首家可提供 全方位虚拟资产服务的中资券商，契合市场现阶段较为火热的"稳定币"主题机会，在映射效应下，A股 券商板块也实现联动。此外，上周刚举行的陆家嘴论坛发布了科创板"1+6"改革措施，制度包容性提升 助推市场活跃度的改善，1.5万亿元 ...

Core Viewpoint - The report from CITIC Securities indicates that the demand for AI large model training and inference is continuously growing, with system-level computing expected to become the next generation of AI computing infrastructure [1] Group 1: System-Level Computing - System-level computing is anticipated to become the next generation of AI computing infrastructure, driven by the need for generality in foundational infrastructure to address future model developments [1] - The scaling law is rapidly evolving in post-training and online inference stages, with innovations in model architecture enhancing training capabilities [1] - The focus on hardware deployment for achieving higher throughput and lower latency in inference is becoming critical, with a shift towards cluster-based inference models [1] Group 2: Technical Aspects - The development of single-chip computing capabilities is outpacing advancements in communication technology, making communication efficiency a key factor for cluster performance [3] - Two primary methods for building large clusters are identified: Scale up (increasing resources per node) and Scale out (increasing the number of nodes), with Scale up being a significant future direction [3] - Notable examples include NVIDIA's NVL72 system and Huawei's CloudMatrix384 super node, which provide insights into industry development [3] Group 3: Industry Dynamics - The semiconductor industry typically utilizes mergers and acquisitions for technology integration and market expansion, with leading companies often pursuing these strategies to enhance their market position [4] - NVIDIA's acquisition of Mellanox exemplifies this strategy, expanding its NVLink technology to include RDMA networks for large-scale computing [4] - AMD's acquisition of ZT Systems has strengthened its system architecture design capabilities and data center solution delivery experience, contributing to the core of AI solutions [4][5]

Core Viewpoint - CITIC Securities expects that conventional liquidity tools such as MLF and reverse repos will maintain net injection of liquidity [1] Group 1: MLF and Reverse Repo - In June 2025, MLF is projected to maintain an excess rollover with a net injection of 118 billion yuan [1] - Both MLF and reverse repos achieved net liquidity injection, providing long-term liquidity supply [1] - There is a possibility of a decline in MLF bidding rates due to the downward trend in the central rate of time deposits [1] Group 2: Liquidity Outlook - The observation period for total tools indicates a sustained demand for ample liquidity [1] - It is anticipated that MLF and reverse repos will continue to maintain net liquidity injection under the current conditions [1]

中信证券资产管理有限公司已于2025年6月24日在管理人网站（www.citicsam.com）及《中国证券报》 披露了《中信证券资产管理有限公司关于以通讯方式召开中信证券现金添利货币型集合资产管理计划集 合计划份额持有人大会的公告》，并于2025年6月25日在上述网站和报刊上发布了《中信证券资产管理 有限公司关于以通讯方式召开中信证券现金添利货币型集合资产管理计划集合计划份额持有人大会的第 一次提示性公告》，为了使本次集合计划份额持有人大会顺利召开，现发布《中信证券资产管理有限公 司关于以通讯方式召开中信证券现金添利货币型集合资产管理计划集合计划份额持有人大会的第二次提 示性公告》。 一、会议基本情况 根据中国证监会于2018年11月28日发布的《证券公司大集合资产管理业务适用〈关于规范金融机构资产 管理业务的指导意见〉操作指引》（证监会公告〔2018〕39号，以下简称"《操作指引》"）的规定，中 信证券现金添利货币型集合资产管理计划（以下简称"本集合计划"）经中国证监会2022年6月7日《关于 准予广州证券红棉现金宝集合资产管理计划合同变更的回函》（机构部函【2022】1071号）准予，由广 州证券红棉现 ...

Core Viewpoint - China Construction Bank Corporation is issuing A-shares to specific investors, with the aim of raising capital to strengthen its core tier one capital and support sustainable business development [12][15]. Group 1: Basic Information about the Issuer - Company Name: China Construction Bank Corporation [2] - Legal Representative: Zhang Jinliang [2] - Established Date: September 17, 2004 [2] - Registered Capital: 250.01 billion CNY [2] - Headquarters: Financial Street, Xicheng District, Beijing [2] - Total Assets: 40,571.15 billion CNY as of December 31, 2024 [6] - Total Liabilities: 37,227.18 billion CNY as of December 31, 2024 [6] - Total Equity: 3,343.97 billion CNY as of December 31, 2024 [6] Group 2: Business Overview - The issuer is a leading state-owned commercial bank in China, providing comprehensive financial services to 771 million individual customers and 11.68 million corporate clients [3]. - Main business segments include corporate banking, personal banking, asset management, and other services including overseas operations [4][5]. Group 3: Financial Performance - Total Operating Income for 2024: 750.15 billion CNY, a decrease from 769.74 billion CNY in 2023 [5]. - Operating Profit for 2024: 384.27 billion CNY, slightly down from 389.23 billion CNY in 2023 [5]. - Net Profit Attributable to Shareholders: 335.58 billion CNY for 2024, compared to 332.65 billion CNY in 2023 [5]. Group 4: Issuance Details - Type of Shares: A-shares with a par value of 1.00 CNY each [12]. - Issuance Method: Directed issuance to specific investors, specifically the Ministry of Finance [12][13]. - Issuance Price: Initially set at 9.27 CNY per share, adjusted to 9.06 CNY after dividend distribution [13][14]. - Total Number of Shares Issued: 11,589,403,973 shares, not exceeding 30% of the total share capital prior to issuance [15]. Group 5: Use of Proceeds - Total proceeds from the issuance are expected to be 105 billion CNY, which will be used entirely to supplement the issuer's core tier one capital [15]. Group 6: Regulatory Compliance - The issuance has been approved by the China Banking Regulatory Commission and has passed the review of the Shanghai Stock Exchange [24][25]. - The issuer has followed necessary decision-making procedures as per the Company Law and Securities Law [23][24]. Group 7: Underwriter Information - CITIC Securities is the underwriter for this issuance, ensuring compliance with relevant laws and regulations [12][22]. - Key representatives from CITIC Securities include Zhou Yu and Shi Guoping, both with extensive experience in underwriting and securities issuance [16][17].

Core Viewpoint - The report outlines the financial advisor's verification opinion regarding the equity change report of Shandong Pharmaceutical Glass Co., Ltd, confirming compliance with relevant laws and regulations, and the accuracy of the disclosed information [2][3][7]. Group 1: Verification of Equity Change Report - The financial advisor conducted a thorough review of the equity change report, ensuring it meets the requirements of the Securities Law and other relevant regulations [7][8]. - No false records, misleading statements, or significant omissions were found in the equity change report [3][7]. Group 2: Basic Information of Disclosing Obligors - The disclosing obligors include China International Medical Health Co., Ltd and Sinopharm International Hong Kong Co., Ltd, both of which are wholly owned subsidiaries of Sinopharm Group [5][9]. - China International Medical Health Co., Ltd has a registered capital of 500 million yuan and is a state-owned enterprise [9][10]. Group 3: Equity Structure and Control Relationships - Sinopharm International is the controlling shareholder of Sinopharm International Hong Kong, which is a wholly owned subsidiary [11][12]. - The controlling shareholder of Sinopharm International is Sinopharm Group, which has not changed in the last two years [12][14]. Group 4: Purpose of Equity Change - The equity change aims to enhance the core competitiveness of Sinopharm Group and support the development of strategic emerging industries [23][24]. - After the equity change, Sinopharm International will focus on building a world-class pharmaceutical materials industry chain [23][25]. Group 5: Financial Data of Disclosing Obligors - For the year ending December 31, 2024, China International Medical Health Co., Ltd reported total assets of 2,211,697.55 million yuan and total liabilities of 970,789.75 million yuan [16]. - Sinopharm International Hong Kong reported total assets of 279,837.80 million yuan for the same period [16].

利弗莫尔证券显示，上海商米科技集团股份有限公司向港交所提交上市申请书，联席保荐人为 德意志 银行、 中信证券和农银国际。 ...

6月25日，香港证券ETF（513090）延续强势表现，盘中最高触及1.89元，刷新2020年3月上市以来的历 史纪录。截至收盘，该ETF报1.875元，单日涨幅达8.51%，连续三个交易日累计上涨16.75%，单日成交 额突破270亿元，同样创下上市以来的单日历史新高。 从持仓来看，作为市场唯一跟踪中证香港证券投资主题指数的产品，香港证券ETF持仓高度集中于香港 头部券商，前十大重仓股包括香港交易所、中信证券、国泰海通等。受利好消息刺激，截至6月25日收 盘，香港证券ETF成分股全线飘红： 消息面上，国泰君安国际正式获得香港证监会批准，将其现有证券牌照升级为可提供虚拟资产交易及相 关意见服务的综合牌照，成为首家获此全方位虚拟资产交易服务资格的香港中资券商。获批后，国泰君 安国际客户将可直接通过平台交易比特币、以太坊等主流加密货币及稳定币。 此外，近期市场情绪全面回暖。6月25日沪指突破3月高点，收盘报3455.97点，创年内新高；港股市场 亦集体走强，富时中国A50指数期货午后涨超1%。券商股大涨，成为两市领涨主力。国泰君安国际大 涨198.39%，弘业期货涨超33%，申万宏源涨超14%。天风证券、湘财股份 ...

据券商中国记者不完全统计，今年以来共有24家上市券商公告获批发行债券，合计获批规模达4757亿元，高于 上年同期水平。与此同时，已有70家券商在境内发行债券约5621.68亿元，亦实现同比增长。 近日，信达证券连续发布两则公开发债获批公告，分别是获批发行不超过39亿元永续次级债，以及不超过 100亿元公司债券，折射出当下券商发债融资积极性正在提升。 在发债规模回升的同时，记者发现，券商发债融资正迎来一些变化：科技创新债券等新品种涌现、永续债发行 增多、融资成本进一步下滑。 4757亿元发债融资申请获批，呈现三大特点 2024年，证券公司发债融资的步伐有所放缓。但进入2025年以后，券商发债融资积极性又开始回升，尤其是3 月份以后。以6月为例，目前刚至下旬，已有6家上市券商公告向专业投资者公开发行债券的申请获批，合计获 批额度为1077亿元。 根据券商中国记者统计和观察，与2024年上半年相比，今年券商发债融资获批的整体情况呈现三大特点： 一是券商发债融资获批的总规模有所增长。 从上市券商的情况来看，截至6月22日，2025年内已有24家券商公 告称，发债融资申请获得监管批复，合计获批额度为4757亿元。相较上 ...